Funakoshi Co., Ltd. joins our distributor network
490 BioTech is proud to announce that Funakoshi Co., Ltd. has joined our distributor network to serve our research clientele in Japan.
490 BioTech is proud to announce that Funakoshi Co., Ltd. has joined our distributor network to serve our research clientele in Japan.
490 BioTech is pleased to announce the acquisition of a Phase II SBIR award from the National Institutes of Health, National Institute of General Medical Sciences for the development of new high-throughput drug discovery screens
490 BioTech is pleased to announce a Phase II STTR award from the National Institutes of Health, National Institute of General Medical Sciences, that will enable the development of novel in vitro cellular and in
490 BioTech’s Conflict of Interest policy is available for public review at this LINK.
490 BioTech is pleased to announce distributor partnerships with Applied StemCell (USA, Japan), Proteigene (European Union, United Kingdom), and BioAspect Services About Applied StemCell: “Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered
490 BioTech is proud to announce that Funakoshi Co., Ltd. has joined our distributor network to serve our research clientele in Japan.
490 BioTech is pleased to announce the acquisition of a Phase II SBIR award from the National Institutes of Health, National Institute of General Medical Sciences for the development of new high-throughput drug discovery screens
490 BioTech is pleased to announce a Phase II STTR award from the National Institutes of Health, National Institute of General Medical Sciences, that will enable the development of novel in vitro cellular and in
490 BioTech’s Conflict of Interest policy is available for public review at this LINK.
490 BioTech is pleased to announce distributor partnerships with Applied StemCell (USA, Japan), Proteigene (European Union, United Kingdom), and BioAspect Services About Applied StemCell: “Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered
490 BioTech is proud to announce that Funakoshi Co., Ltd. has joined our distributor network to serve our research clientele in Japan.
490 BioTech is pleased to announce the acquisition of a Phase II SBIR award from the National Institutes of Health, National Institute of General Medical Sciences for the development of new high-throughput drug discovery screens
490 BioTech is pleased to announce a Phase II STTR award from the National Institutes of Health, National Institute of General Medical Sciences, that will enable the development of novel in vitro cellular and in
490 BioTech’s Conflict of Interest policy is available for public review at this LINK.
490 BioTech is pleased to announce distributor partnerships with Applied StemCell (USA, Japan), Proteigene (European Union, United Kingdom), and BioAspect Services About Applied StemCell: “Applied StemCell Inc. (ASC) is a fast growing biotechnology company headquartered